Novel 2009 H1N1 influenza virus infection requiring extracorporeal membrane oxygenation in a pediatric heart transplant recipient
| Autor: | Stephen Davis, Charles B. Foster, Colleen Nasman, Nicholas G. Smedira, John c Carl, Charles Kwon, Lara Danziger-Isakov, Aron Flagg, Gerard J. Boyle |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Male
Pulmonary and Respiratory Medicine ARDS medicine.medical_specialty Heart disease medicine.medical_treatment Orthomyxoviridae Opportunistic Infections Intensive Care Units Pediatric Antiviral Agents Virus Extracorporeal Membrane Oxygenation Influenza A Virus H1N1 Subtype Oseltamivir Postoperative Complications Internal medicine Influenza Human medicine Extracorporeal membrane oxygenation Humans Child Intensive care medicine Respiratory Distress Syndrome Transplantation biology business.industry Respiratory disease virus diseases medicine.disease biology.organism_classification Combined Modality Therapy Pneumonia Heart Transplantation Surgery Cardiology and Cardiovascular Medicine business |
| Zdroj: | The Journal of Heart and Lung Transplantation. 29:582-584 |
| ISSN: | 1053-2498 |
| DOI: | 10.1016/j.healun.2009.11.600 |
| Popis: | The novel 2009 H1N1 influenza virus has been reported to have increased severity in patients with underlying cardiovascular and lung disease. Pediatric patients also appear to have an increased incidence of infection. The impact on cardiothoracic transplant recipients, especially in pediatric recipients, has not been established. We report the case of a 12-year-old boy with history of congenital heart disease who was transplanted in June 2001. In October 2009, it was found that he had developed severe acute respiratory distress syndrome (ARDS) secondary to novel 2009 H1N1 influenza virus. Extracorporeal membrane oxygenation (ECMO) was given as support. Importantly, the initial specimen evaluated by real-time reverse transcriptase-polymerase chain reaction was negative for novel 2009 H1N1 influenza virus. The patient was successfully weaned from ECMO after 24 days, extubated at 6 weeks, and continues to make steady rehabilitative progress. Early suspicion for infection and initiation of treatment, even with negative testing, is essential for cardiothoracic transplant recipients during the current pandemic of novel 2009 H1N1 influenza virus. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|